Insider Transactions in Q3 2025 at Phathom Pharmaceuticals, Inc. (PHAT)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 25
2025
|
Steven L Basta President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
48,375
-53.75%
|
$532,125
$11.66 P/Share
|
|
Sep 25
2025
|
Steven L Basta President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
90,000
+50.0%
|
-
|
|
Sep 05
2025
|
Robert Charles Breedlove Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
461
-0.95%
|
$5,532
$12.09 P/Share
|
|
Jul 16
2025
|
Robert Charles Breedlove Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,692
-3.38%
|
$13,536
$8.36 P/Share
|